Nutritional supplements are often recommended or sold by practitioners such as chiropractors, naturopathic doctors and other providers. Determining what ingredients are in the products is difficult and a recent settlement shows that retailers will be held responsible for selling products with misbranded supplements or that promise to treat or cure a disease.
All providers who sell supplements should ensure that the products do not include unlawful dietary supplements to the extent possible. How can a retailer determine if supplements are from natural plants or are synthetic?
On December 7, 2016, the
world’s largest dietary supplement retailer, GNC Holdings Inc. (GNC), entered into a wide-ranging agreement with the Department of Justice to reform
its practices related to potentially unlawful dietary ingredients and dietary
supplements, and has further promised to embark on a series of voluntary
initiatives designed to improve the quality and purity of dietary supplements.
The non-prosecution agreement
resolves GNC’s liability for selling certain dietary supplements produced by a
firm currently under indictment. As part of the agreement, GNC has agreed
to pay $2.25 million to the U.S. government and cooperate in dietary supplement
investigations conducted by the government.
A
lengthy investigation conducted by the U.S. Food and Drug Administration (FDA),
the U.S. Attorney’s Office for the Northern District of Texas, and the Consumer
Protection Branch of the Department of Justice’s Civil Division resulted in allegations that
GNC’s practices related to ensuring the legality of products on its shelves
were lacking.
According
to an agreed-upon statement of facts that accompanies the non-prosecution
agreement, GNC admitted it engaged in acts and omissions that allowed a misbranded
supplement— OxyElite Pro Advanced Formula, a product of Dallas-based USPlabs
LLC (USP Labs)—to be sold at GNC locations nationwide in 2013. The
statement of facts notes that GNC sold the product based on representations
from USP Labs that ingredients contained in the product complied with the
law. It further notes that GNC did not undertake additional testing or
require additional certifications to confirm such representations or to verify
that the ingredients in the product were as represented.
USP
Labs was indicted in
November 2015 and is awaiting trial. The indictment alleges, among other
things, that USP Labs engaged in a conspiracy to import ingredients from China
using false certificates of analysis and false labeling, and then lied about
the source and nature of those ingredients after it put them in its
products. According to the indictment, USP Labs told some of its
retailers and wholesalers that it used natural plant extracts in some of its products,
when in fact it was using synthetic stimulants manufactured in a Chinese
chemical factory.